Gene Transfer of Inducible Nitric Oxide Synthase Affords Cardioprotection by Upregulating Heme Oxygenase-1 Via a Nuclear Factor-&kgr;B–Dependent Pathway

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Circulation

• Publication date

  2009-09-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.108.778688PMID 19752329PMCID PMC2768612
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of transcription factor-DNA interactions using chromatin immunoprecipitation assays.

  2009cited by this paper
• Heme Oxygenase-1 Regulates Cardiac Mitochondrial Biogenesis via Nrf2-Mediated Transcriptional Control of Nuclear Respiratory Factor-1

  2008cited by this paper
• Shared principles in NF-kappaB signaling.

  2008cited by this paper
• SELECTIVE REGULATION OF HEME OXYGENASE-1 EXPRESSION AND FUNCTION BY INSULIN THROUGH IRS1/PI3-KINASE/AKT-2 PATHWAY

  2008cited by this paper
• Interaction Among Heme Oxygenase, Nuclear Factor-&kgr;B, and Transcription Activating Factors in Cardiac Hypertrophy in Hypertension

  2008cited by this paper
• Selective Regulation of Heme Oxygenase-1 Expression and Function by Insulin through IRS1/Phosphoinositide 3-Kinase/Akt-2 Pathway*

  2008cited by this paper
• Cardioprotection Afforded by Inducible Nitric Oxide Synthase Gene Therapy Is Mediated by Cyclooxygenase-2 via a Nuclear Factor-&kgr;B-Dependent Pathway

  2007cited by this paper
• How many transcription factors does it take to turn on the heme oxygenase-1 gene?

  2007cited by this paper
• Preconditioning: a paradigm shift in the biology of myocardial ischemia.

  2007cited by this paper
• Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease.

  2007cited by this paper
• Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats.

  2007cited by this paper
• The late phase of preconditioning and its natural clinical application—gene therapy

  2007cited by this paper
• Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences.

  2006cited by this paper
• Protective effect of carbon monoxide in transplantation

  2006cited by this paper
• Selectivity of imidazole–dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms

  2006cited by this paper
• Novel one-step real-time RT-PCR assay for rapid and specific diagnosis of Crimean-Congo hemorrhagic fever encountered in the Balkans.

  2006cited by this paper
• Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications.

  2006cited by this paper
• The ubiquitous role of nitric oxide in cardioprotection.

  2006cited by this paper
• Heme oxygenase-1: a novel drug target for atherosclerotic diseases?

  2006cited by this paper
• Haploinsufficiency of the cardiac transcription factor Nkx2‐5 variably affects the expression of putative target genes

  2005cited by this paper
• HO-1 induction by HIF-1: a new mechanism for delayed cardioprotection?

  2005cited by this paper
• 30 some years of heme oxygenase: from a "molecular wrecking ball" to a "mesmerizing" trigger of cellular events.

  2005cited by this paper
• Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo.

  2004cited by this paper
• Probucol Protects Against Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1

  2004cited by this paper
• A cis-Acting Region Regulates Oxidized Lipid-Mediated Induction of the Human Heme Oxygenase-1 Gene in Endothelial Cells

  2003cited by this paper
• Rapamycin Induces Heme Oxygenase-1 in Human Pulmonary Vascular Cells: Implications in the Antiproliferative Response to Rapamycin

  2003cited by this paper
• Carbon Monoxide Protects against Liver Failure through Nitric Oxide–induced Heme Oxygenase 1

  2003cited by this paper
• Cardiac-Specific Expression of Heme Oxygenase-1 Protects Against Ischemia and Reperfusion Injury in Transgenic Mice

  2001cited by this paper
• Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research.

  2001cited by this paper
• Cardiac-specific Abrogation of NF- κ B Activation in Mice by Transdominant Expression of a Mutant Iκ B α

  2001cited by this paper
• Heme oxygenase-1 protects the heart.

  2001cited by this paper
• Exacerbation of Chronic Renovascular Hypertension and Acute Renal Failure in Heme Oxygenase-1–Deficient Mice

  2001cited by this paper
• Cardiac-specific abrogation of NF- kappa B activation in mice by transdominant expression of a mutant I kappa B alpha.

  2001cited by this paper
• Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction.

  2000cited by this paper
• Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice.

  1999cited by this paper
• The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene.

  1999cited by this paper
• Nitric oxide induces heme oxygenase-1 gene expression in mesangial cells.

  1999cited by this paper
• Transcriptional activation of the haem oxygenase-1 gene by cGMP via a cAMP response element/activator protein-1 element in primary cultures of rat hepatocytes.

  1998cited by this paper
• Demonstration of an early and a late phase of ischemic preconditioning in mice.

  1998cited by this paper
• Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy

  1996cited by this paper
• J. Virol. Methods

  1996cited by this paper
• IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice

  1996cited by this paper
• Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene.

  1994cited by this paper
• Isolation and characterization of the mouse heme oxygenase-1 gene. Distal 5' sequences are required for induction by heme or heavy metals.

  1994cited by this paper
• I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

  1988cited by this paper
• EncephalomyelitisExperimental Autoimmune Immunomodulatory Activity and Suppresses Bilirubin Possesses Powerful

  year unknowncited by this paper
• Nuclear Factor- (cid:107) B Plays an Essential Role in the Late Phase of Ischemic Preconditioning in Conscious Rabbits

  year unknowncited by this paper

• Heme Oxygenase-1 and Its Role in Colorectal Cancer

  2023cites this paper
• Protection Against Post-resuscitation Acute Kidney Injury by N-Acetylcysteine via Activation of the Nrf2/HO-1 Pathway

  2022cites this paper
• Carvacrol mitigates vancomycin-induced nephrotoxicity via regulation of IkBα/p38MAPK and Keap1/Nrf2 signaling pathways: an experimental study with in silico evidence.

  2022cites this paper
• Tetramethylpyrazine: An Active Ingredient of Chinese Herbal Medicine With Therapeutic Potential in Acute Kidney Injury and Renal Fibrosis

  2022cites this paper
• Effects of Heme Oxygenase-1 on c-Kit-Positive Cardiac Cells

  2021cites this paper
• Crocin ameliorates arsenic trioxide‑induced cardiotoxicity via Keap1-Nrf2/HO-1 pathway: Reducing oxidative stress, inflammation, and apoptosis.

  2020cites this paper
• Modulation of Inflammation and Immune Responses by Heme Oxygenase-1: Implications for Infection with Intracellular Pathogens

  2020cites this paper
• Hepatocellular iNOS protects liver from NASH through Nrf2-dependent activation of HO-1.

  2019cites this paper
• Bone marrow-derived mesenchymal stromal cells ameliorate severe acute pancreatitis in rats via hemeoxygenase-1-mediated anti-oxidant and anti-inflammatory effects.

  2019cites this paper
• Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.

  2019cites this paper
• The macrophage heme-heme oxygenase-1 system and its role in inflammation.

  2018cites this paper
• Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction

  2017cites this paper
• Heme oxygenase in cardiac repair and regeneration.

  2016cites this paper
• Hyperbaric oxygen preconditioning ameliorates hypoxia–ischemia brain damage by activating Nrf2 expression in vivo and in vitro

  2016cites this paper
• Overexpression of heme oxygenase-1 induced by constitutively activated NF-κB as a potential therapeutic target for activated B-cell-like diffuse large B-cell lymphoma.

  2016cites this paper
• Exercise does not activate the β3 adrenergic receptor–eNOS pathway, but reduces inducible NOS expression to protect the heart of obese diabetic mice

  2016cites this paper
• Nitrite Therapy Ameliorates Myocardial Dysfunction via H2S and Nuclear Factor‐Erythroid 2‐Related Factor 2 (Nrf2)‐Dependent Signaling in Chronic Heart Failure

  2016cites this paper
• Preconditioning c-Kit-positive Human Cardiac Stem Cells with a Nitric Oxide Donor Enhances Cell Survival through Activation of Survival Signaling Pathways*

  2016cites this paper
• Effect of Tumor Necrosis Factorα on Expression of Heme-Oxgenase 1 in Human Gingival Fibroblasts

  2015cites this paper
• Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet

  2015cites this paper
• Hydrogen Sulfide Levels and Nuclear Factor-Erythroid 2-Related Factor 2 (NRF2) Activity Are Attenuated in the Setting of Critical Limb Ischemia (CLI)

  2015cites this paper
• Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS

  2015cites this paper
• Preconditioning Human Cardiac Stem Cells with an HO‐1 Inducer Exerts Beneficial Effects After Cell Transplantation in the Infarcted Murine Heart

  2015cites this paper
• Hydrogen gas inhalation protects against liver ischemia/reperfusion injury by activating the NF-κB signaling pathway.

  2015cites this paper
• PECAM-1-dependent regulation and protective effects of Heme Oxygenase-1 in the endothelium

  2015cites this paper
• Agonists of epoxyeicosatrienoic acids reduce infarct size and ameliorate cardiac dysfunction via activation of HO-1 and Wnt1 canonical pathway.

  2015cites this paper
• Melatonin modulates microsomal PGE synthase 1 and NF-E2-related

  2014cites this paper
• c-kit+ Cardiac Stem Cells Alleviate Post-Myocardial Infarction Left Ventricular Dysfunction Despite Poor Engraftment and Negligible Retention in the Recipient Heart

  2014cites this paper
• Protective Vascular and Cardiac Effects of Inducible Nitric Oxide Synthase in Mice with Hyperhomocysteinemia

  2014cites this paper
• Melatonin modulates microsomal PGE synthase 1 and NF‐E2‐related factor‐2‐regulated antioxidant enzyme expression in LPS‐induced murine peritoneal macrophages

  2014cites this paper
• Moxonidine modulates cytokine signalling and effects on cardiac cell viability.

  2014cites this paper
• Effect of Tumor Necrosis Factorα on Expression of Heme-Oxgenase1 in Human Gingival Fibroblasts

  2014cites this paper
• A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice

  2013cites this paper
• H S Protects Against Pressure Overload–Induced Heart Failure via Upregulation of Endothelial Nitric Oxide Synthase

  2013cites this paper
• Arginine, Tetrahydrobiopterin, and Nitric Oxide in Myocardial Protection

  2013cites this paper
• The involvement of heme oxygenase 1 but not nitric oxide synthase 2 in a hepatoprotective action of quercetin in lipopolysaccharide-induced hepatotoxicity of D-galactosamine sensitized rats.

  2013cites this paper
• Redox Control of Leukemia: From Molecular Mechanisms to Therapeutic Opportunities

  2013cites this paper
• H2S Protects Against Pressure Overload–Induced Heart Failure via Upregulation of Endothelial Nitric Oxide Synthase

  2013cites this paper
• Carbon monoxide: mechanisms of action and potential clinical implications.

  2013cites this paper
• Hydrogen Sulfide Attenuates Cardiac Dysfunction After Heart Failure Via Induction of Angiogenesis

  2013cites this paper
• Modulation of Myocardial Genes via Use of Adenoviral Vectors and RNA Interference Approaches

  2013cites this paper
• NOS2 Induction and HO-1-Mediated Transcriptional Control in Gram-Negative Peritonitis

  2013cites this paper
• Identification of inducible nitric oxide synthase in peripheral blood cells as a mediator of myocardial ischemia/reperfusion injury

  2012cites this paper
• Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium.

  2012cites this paper
• The COX-2/PGI2 Receptor Axis Plays an Obligatory Role in Mediating the Cardioprotection Conferred by the Late Phase of Ischemic Preconditioning

  2012cites this paper
• Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences

  2011cites this paper
• Oxygenase-1 Inflammation by Inhibition of Heme Results in Enhanced Helicobacter pylori Disruption of Nitric Oxide Signaling by Peek

  2011cites this paper
• Disruption of Nitric Oxide Signaling by Helicobacter pylori Results in Enhanced Inflammation by Inhibition of Heme Oxygenase-1

  2011cites this paper
• Cardiac muscle regeneration: lessons from development.

  2011cites this paper
• Repair of Acute Myocardial Infarction by Human Stemness Factors Induced Pluripotent Stem Cells

  2011cites this paper
• The extracellular matrix metalloproteinase inducer EMMPRIN is a target of nitric oxide in myocardial ischemia/reperfusion.

  2011cites this paper
• Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models

  2011cites this paper
• Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences

  2011cites this paper
• Circulation Editors' Picks: Most Read Articles in Molecular Cardiology

  2011cites this paper
• Gene therapy for ischemic heart disease.

  2011cites this paper
• Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential.

  2010cites this paper
• Cardiac specific transgenic inhibition of nuclear factor-kappaB (NF-kappaB) mitigates adverse cardiac remodeling and ameliorates cardiac dysfunction in doxorubicin-induced cardiomyopathy

  2010cites this paper
• NF-kappaB driven cardioprotective gene programs; Hsp70.3 and cardioprotection after late ischemic preconditioning.

  2010cites this paper
• Heme oxygenase-1 in cardiovascular diseases

  2010cites this paper